Recurrent miscarriage
85 results
1 - 85
Recurrent miscarriage 
Aspirin = enoxaparin for prevention of recurrent miscarriage- Anticoagulation ineffective for recurrent miscarriage
- Progestogen for preventing miscarriage in women with recurrent miscarriage
Chinese herbal medicines for unexplained recurrent miscarriage- Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology
- Progesterone does not prevent recurrent miscarriage (PROMISE)
- Immunotherapy for recurrent miscarriage: Cochrane systematic review
- Human chorionic gonadotrophin for recurrent miscarriage: Cochrane systematic review
- Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history
- Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia
- Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
- Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
- Progestogens for preventing miscarriage: a network meta‐analysis
- Bleeding during first and second trimesters of pregnancy
- Human chorionic gonadotrophin (hCG) for preventing miscarriage: Cochrane systematic review
- Bed rest during pregnancy for preventing miscarriage
- Systemic lupus erythematosus (SLE)
- Aspirin or anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome
- Threatened premature labour
- Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)
- GM‐CSF (granulocyte macrophage colony‐stimulating factor) supplementation in culture media for women undergoing assisted reproduction
- Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
- Nonsteroidal anti‐inflammatory drugs for assisted reproductive technology
- Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies
- Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction
- Septum resection for women of reproductive age with a septate uterus
- Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy
- Autologous platelet‐rich plasma for assisted reproduction
- Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
- Turner syndrome
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
- Cervical stitch (cerclage) for preventing pregnancy loss in women
- Chronic diseases and pregnancy
- Antenatal clinics: care and examinations